747 related articles for article (PubMed ID: 28634044)
1. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation.
Wang Y; Zhou X; Shan B; Han J; Wang F; Fan X; Lv Y; Chang L; Liu W
Mol Med Rep; 2015 Nov; 12(5):6491-500. PubMed ID: 26352175
[TBL] [Abstract][Full Text] [Related]
3. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
[TBL] [Abstract][Full Text] [Related]
5. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.
Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB
J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956
[TBL] [Abstract][Full Text] [Related]
7. MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression.
He J; Ge Q; Lin Z; Shen W; Lin R; Wu J; Wang B; Lu Y; Chen L; Liu X; Zheng W; Zhang Y; Wang L; Wang K; Wang L; Zhuo W; Chen S
FASEB J; 2020 Jun; 34(6):8544-8557. PubMed ID: 32356314
[TBL] [Abstract][Full Text] [Related]
8. The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.
Huang TT; Ping YH; Wang AM; Ke CC; Fang WL; Huang KH; Lee HC; Chi CW; Yeh TS
Oncotarget; 2015 Jul; 6(20):18012-26. PubMed ID: 26041881
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibitory effects of three miR-129 family members on gastric cancer.
Yu X; Song H; Xia T; Han S; Xiao B; Luo L; Xi Y; Guo J
Gene; 2013 Dec; 532(1):87-93. PubMed ID: 24055727
[TBL] [Abstract][Full Text] [Related]
10. miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells.
Feng L; Xie Y; Zhang H; Wu Y
Med Oncol; 2012 Jun; 29(2):856-63. PubMed ID: 21264532
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression.
Xu YY; Song YQ; Huang ZM; Zhang HB; Chen M
Kaohsiung J Med Sci; 2019 May; 35(5):277-283. PubMed ID: 30897301
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways.
Shin SS; Park SS; Hwang B; Moon B; Kim WT; Kim WJ; Moon SK
Oncol Rep; 2016 Oct; 36(4):2313-20. PubMed ID: 27573859
[TBL] [Abstract][Full Text] [Related]
13. miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A.
Yang X; Feng M; Jiang X; Wu Z; Li Z; Aau M; Yu Q
Genes Dev; 2009 Oct; 23(20):2388-93. PubMed ID: 19833767
[TBL] [Abstract][Full Text] [Related]
14. LINC00319 acts as a
Zou J; Wu K; Lin C; Jie ZG
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G10-G22. PubMed ID: 31433213
[TBL] [Abstract][Full Text] [Related]
15. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.
Zheng L; Qi T; Yang D; Qi M; Li D; Xiang X; Huang K; Tong Q
PLoS One; 2013; 8(1):e55719. PubMed ID: 23383271
[TBL] [Abstract][Full Text] [Related]
16. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor.
Tie J; Pan Y; Zhao L; Wu K; Liu J; Sun S; Guo X; Wang B; Gang Y; Zhang Y; Li Q; Qiao T; Zhao Q; Nie Y; Fan D
PLoS Genet; 2010 Mar; 6(3):e1000879. PubMed ID: 20300657
[TBL] [Abstract][Full Text] [Related]
17. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
Hu J; Fang Y; Cao Y; Qin R; Chen Q
Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
[TBL] [Abstract][Full Text] [Related]
18. MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1.
Bao C; Chen J; Chen D; Lu Y; Lou W; Ding B; Xu L; Fan W
Cell Death Dis; 2020 Aug; 11(8):618. PubMed ID: 32796817
[TBL] [Abstract][Full Text] [Related]
19. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway.
Wang S; Wang X; Gao Y; Peng Y; Dong N; Xie Q; Zhang X; Wu Y; Li M; Li JL
J Pathol; 2019 Jun; 248(2):204-216. PubMed ID: 30714150
[TBL] [Abstract][Full Text] [Related]
20. MiR-186 represses progression of renal cell cancer by directly targeting CDK6.
Guo Z; Lv X; Jia H
Hum Cell; 2020 Jul; 33(3):759-767. PubMed ID: 32266659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]